Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

Merck KGaA, Pfizer’s Bavencio stumbles in head and neck cancer

Merck KGaA, Pfizer’s Bavencio stumbles in head and neck cancer Opdivo (nivolumab).

AstraZeneca’s Imfinzi fails first-line bladder cancer test

AstraZeneca’s Imfinzi fails first-line bladder cancer test inhibitors including Bristol-Myers Squibb’s Opdivo (nivolumab) and Merck KGaA/Pfizer’s Bavencio (avelumab).

Putting commercial intelligence at the heart of strategy

Putting commercial intelligence at the heart of strategy Merck Sharp &Dohme (MSD), the company that markets Keytruda, and Bristol-Myers Squibb (BMS), the company that markets Opdivo, approached development of their respective products in this area with starkly contrasting

BMS partners with Voluntis to co-develop oncology digital therapeutics

BMS partners with Voluntis to co-develop oncology digital therapeutics Although not stated in the news announcement, that could include BMS’ checkpoint inhibitor Opdivo (nivolumab), which is indicated for use across a number of cancer types.

Modest meeting sees only two drugs recommended by CHMP

Modest meeting sees only two drugs recommended by CHMP The CHMP also noted the withdrawal of Bristol-Myers Squibb’s Opdivo (nivolumab) and Yervoy (iplimumab) application, which was seeking marketing authorisation in first-line metastatic non-small cell lung cancer.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics